Prime Medicine, Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

4.040

+0.300 (8.02%)

At close: Aug 1, 2025, 4:00 PM

4.240

+0.200 (4.95%)

Pre-market: Aug 4, 2025, 4:57 AM EDT

FARO Technologies Employees

Prime Medicine had 214 employees as of December 31, 2024. The number of employees decreased by 20 or -8.55% compared to the previous year.

Employees

214

Change (1Y)

-20

Growth (1Y)

-8.55%

Revenue / Employee

$17,972

Profits / Employee

-$943,977

Market Cap

682.85M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	214	-20	-8.55%
Dec 31, 2023	234	59	33.71%
Dec 31, 2022	175	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

PRME News

2 days ago - Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
4 days ago - Prime Medicine Announces Pricing of Public Offering - GlobeNewsWire
4 days ago - Prime Medicine Announces Proposed Public Offering of Common Stock - GlobeNewsWire
18 days ago - Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy - Business Wire
18 days ago - Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis - GlobeNewsWire
27 days ago - Prime Medicine: Pressing Forward With Lead Liver Targeting Indications - Seeking Alpha
2 months ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
2 months ago - Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition - GlobeNewsWire